Narrative Review Synthesizes Evidence on Extracellular Vesicles for Premature Ovarian Insufficiency and Testicular Damage
Photo by Logan Voss / Unsplash
Key Takeaway
Consider preclinical EV evidence for ovarian failure, noting limitations in standardization and safety data.
This publication is a narrative review examining the therapeutic potential of extracellular vesicles (EVs) derived from mesenchymal stem cells or adipose tissue, bone marrow, placenta, or amniotic membrane. The scope encompasses preclinical models of ovarian and testicular failure, specifically addressing premature ovarian insufficiency, chemotherapy-induced damage, and genetic disorders within these animal systems.
The authors synthesize qualitative conclusions regarding secondary outcomes, including the restoration of folliculogenesis, support of spermatogenesis, and normalization of hormonal profiles. Additional mechanistic arguments involve the regulation of apoptosis, inflammation, fibrosis, and angiogenesis. These findings are presented in the context of comparisons to live-cell transplantation within the preclinical setting.
The authors acknowledge several critical limitations affecting the interpretation of these preclinical data. Specific challenges noted include EV heterogeneity, the standardization of isolation methods, and the development of effective delivery strategies. Safety data regarding adverse events, serious adverse events, and tolerability were not reported in the reviewed literature.
Practice relevance was not reported by the authors, indicating that current evidence does not yet support direct clinical application. The absence of reported sample sizes and follow-up durations further underscores the early stage of this research. Clinicians should recognize that these findings represent preclinical observations rather than established therapeutic standards for human patients.
More on genetic disorders
Cross-sectional analysis of diagnostic yield from exome and genome sequencing in pediatric and prenatal cases.
Genetic Testing Success Varies by Clinic—Here’s Why
This cross-sectional analysis from the CSER consortium examined diagnostic yield from exome and genome sequencing in 3,008 prenatal, neonata…
This study reveals that your odds of getting a genetic diagnosis may depend less on your DNA—and more on where you get tested.
Autologous ovarian grafting may preserve ovarian function in young cervical cancer patients undergoing pelvic radiotherapy
Small trial tests ovarian tissue graft to protect hormone function during cervical cancer radiation
An exploratory phase II randomized trial of 22 women aged ≤35 years with locally advanced cervical cancer found that at six months, 85% of p…
A new trial shows grafting ovarian tissue before cervical cancer radiation kept 85% of young patients' hormone levels normal and prevented e…
View Original Abstract ↓
Gonadal dysfunction resulting from conditions such as premature ovarian insufficiency, chemotherapy-induced damage, or genetic disorders often leads to infertility and hormone imbalance. Although assisted reproductive technologies and hormone replacement therapies mitigate clinical symptoms, they remain incapable of reinstating native gonadal architecture and physiological function. In recent years, stem cell-based therapies, particularly those employing mesenchymal stem cells (MSCs), have demonstrated regenerative potential. However, limitations including poor engraftment, potential tumorigenicity, and ethical concerns, have accelerated the paradigm shift toward extracellular vesicles (EVs) as a safer, cell-free alternative. EVs derived from MSCs are membrane-bound nanovesicles enriched with regulatory microRNAs, proteins, and lipids that exert potent paracrine effects. These vesicles modulate apoptosis, inflammation, fibrosis, and angiogenesis. MSC-EVs can restore folliculogenesis, support spermatogenesis, and normalize hormonal profiles in preclinical models of ovarian and testicular failure. Notably, EVs derived from adipose tissue, bone marrow, placenta, or amniotic membrane exhibit regenerative potential while mitigating the risks associated with live-cell transplantation. This review synthesizes current advances in MSC-EV-based therapies for gonadal regeneration, highlighting their integration into reproductive tissue engineering. Incorporating EVs into decellularized extracellular matrix scaffolds offers promising strategies for targeted tissue repair, extending their application in organoid systems for in vitro gametogenesis, disease modeling, and drug screening. Despite challenges related to EV heterogeneity, standardization of isolation, and delivery strategies, MSCs-derived EVs represent a transformative and ethically sound platform for restoring fertility and endocrine function.
Immune Checkpoint Inhibitors Improve Survival and Response Rates in Patients with Hepatocellular Carcinoma Compared to Standard Therapy
New Drug Gives Liver Cancer Patients More Time
Related in Gastroenterology
Single 6 mg erdafitinib dose shows similar pharmacokinetics in mild or moderate hepatic impairment versus healthy controls.
Single dose of erdafitinib showed no dose changes needed for mild or moderate liver issues
This Phase 1 open-label single-dose study evaluated pharmacokinetics of erdafitinib in 26 participants with hepatic impairment versus health…
A single dose of erdafitinib worked well in people with mild or moderate liver problems, showing no need for dose adjustments.
Five ACLF diagnostic models and prognostic scores identified markedly different proportions of patients at risk of 28-day mortality in a cohort study.
Two new models find the sickest liver patients faster than old tools
This cohort study evaluated five acute-on-chronic liver failure (ACLF) diagnostic models and prognostic scores in 3,370 patients from the CO…
Two new scoring systems find the most dangerous liver failure patients better than older tools, potentially saving lives by catching risk ea…
SABR shows worse survival in ultracentral pulmonary oligometastases compared to nonultracentral tumors
Tumor location matters: ultracentral spots linked to worse survival in lung metastasis patients
This secondary analysis of the SABR-5 Phase 2 trial evaluated progression-free and overall survival in 41 patients with ultracentral pulmona…
Tumor location matters. Patients with ultracentral lung metastases had shorter survival times than those with nonultracentral spots after ra…
SABR in oligometastatic cancer showed median overall survival of 64.6 months in a single-arm phase 2 study.
SABR offers five-year survival hope for patients with limited cancer spread
This single-arm phase 2 trial evaluated stereotactic ablative radiotherapy (SABR) in 380 patients with oligometastatic cancer across six Can…
Patients with few cancer spots lived longer with SABR treatment. Five-year survival reached 58.6 percent in this Canadian study.
From Other Specialties
Late-onset rheumatoid arthritis shows higher DAS28 scores and lower remission rates compared to young-onset disease in a meta-analysis.
Meta-analysis compares treatment outcomes in older versus younger rheumatoid arthritis patients
This meta-analysis reviewed data from over 5000 patients with late-onset rheumatoid arthritis (LORA) and young-onset rheumatoid arthritis (Y…
A large review found older patients with rheumatoid arthritis had higher disease activity and lower remission rates on biologics compared to…
Systematic review and meta-analysis of supervised exercise for foot pain in rheumatoid arthritis
Exercise reduces foot pain and improves function in rheumatoid arthritis
This systematic review and meta-analysis evaluated supervised exercise programs in adults with rheumatoid arthritis and foot involvement. Th…
Supervised exercise programs significantly reduce foot pain and improve physical function in adults with rheumatoid arthritis.
Vitamin D supplementation may reduce disease activity in SLE: a systematic review and meta-analysis
Vitamin D supplements may calm lupus activity, study finds
This systematic review and meta-analysis of 847 patients with systemic lupus erythematosus found that vitamin D supplementation significantl…
A new analysis of 847 lupus patients suggests vitamin D supplements may reduce disease activity and improve immune markers.
Observational study assesses MiniDock MTB diagnostic accuracy against Xpert in Indonesian TB patients
New TB test shows promise in Indonesia trial
This observational study evaluated the diagnostic accuracy of MiniDock MTB on sputum swabs compared to Xpert MTB/RIF Ultra and liquid cultur…
A new TB test called MiniDock MTB accurately detected TB in adults, but sensitivity dropped in children and low-burden cases.